SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina ILMN.O, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese goods took effect.
The ban is part of a series of measures China announced in response to the extra U.S. tariffs and comes after Beijing put Illumina on its "unreliable entity" list in February.
China accounts for about 7% of Illumina's sales.
China's commerce ministry said in a statement that Illumina "violated the principle of normal market transactions, suspended normal transactions with Chinese enterprises and took discriminatory measures against Chinese enterprises, seriously harming the interest of Chinese enterprises.
"Taking into account the circumstances of the company's violation of the law and other factors, the working mechanism of the Unreliability List in accordance with the law made a decision to prohibit it from exporting gene sequencers to China," it said.
Gene sequences help determine the sequence of DNA or RNA to study genetic variations associated with diseases and diagnose rare genetic conditions.
Illumina did not immediately reply to a request for comment.
(Reporting by Andrew Silver; Editing by Miyoung Kim and Kim Coghill)
((miyoung.kim@thomsonreuters.com; 65 6870 3026; Reuters Messaging: miyoung.kim.thomsonreuters.com@reuters.net))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。